Saudi Arabia’s pharmaceuticals market is experiencing a significant transformation, with a projected revenue of US$5.56 billion by 2024. This growth trend is anticipated to continue at a steady rate, with a compound annual growth rate (CAGR) of 6.08% from 2024 to…